Patient adherence and persistence with oral anticancer treatment

Kathryn J Ruddy, Erica Mayer, Ann Partridge

Research output: Contribution to journalArticle

348 Citations (Scopus)

Abstract

Given the recent significant increase in the use of oral therapies in cancer management, an understanding of patients' adherence to and persistence with oral therapy is crucial. Nonadherence and early cessation may be substantial barriers to the delivery of valuable therapies, and may impair health. Potential obstacles to adherence and persistence include personal characteristics, treatment features, and system factors. Techniques for measuring adherence and persistence include self-report, pill counts, microelectronic monitoring systems (MEMS), prescription database analysis, and the assessment of serum or urine drug levels. This review article describes available data regarding adherence and persistence among patients with cancer, as well as studies of interventions to improve adherence. All reports of studies of adherence with oral cancer therapy that the authors could find on PubMed or in the reference sections of these PubMed-located articles were included. Adherence and persistence rates ranged from 16% to 100% with different therapies and different methods of measurement. Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described.

Original languageEnglish (US)
Pages (from-to)56-66
Number of pages11
JournalCA Cancer Journal for Clinicians
Volume59
Issue number1
DOIs
StatePublished - Jan 2009
Externally publishedYes

Fingerprint

Patient Compliance
PubMed
Therapeutics
Mouth Neoplasms
Self Report
Prescriptions
Neoplasms
Urine
Databases
Health
Serum
Pharmaceutical Preparations

ASJC Scopus subject areas

  • Oncology
  • Hematology

Cite this

Patient adherence and persistence with oral anticancer treatment. / Ruddy, Kathryn J; Mayer, Erica; Partridge, Ann.

In: CA Cancer Journal for Clinicians, Vol. 59, No. 1, 01.2009, p. 56-66.

Research output: Contribution to journalArticle

Ruddy, Kathryn J ; Mayer, Erica ; Partridge, Ann. / Patient adherence and persistence with oral anticancer treatment. In: CA Cancer Journal for Clinicians. 2009 ; Vol. 59, No. 1. pp. 56-66.
@article{baeb9345d48b433ba29139385e25bd19,
title = "Patient adherence and persistence with oral anticancer treatment",
abstract = "Given the recent significant increase in the use of oral therapies in cancer management, an understanding of patients' adherence to and persistence with oral therapy is crucial. Nonadherence and early cessation may be substantial barriers to the delivery of valuable therapies, and may impair health. Potential obstacles to adherence and persistence include personal characteristics, treatment features, and system factors. Techniques for measuring adherence and persistence include self-report, pill counts, microelectronic monitoring systems (MEMS), prescription database analysis, and the assessment of serum or urine drug levels. This review article describes available data regarding adherence and persistence among patients with cancer, as well as studies of interventions to improve adherence. All reports of studies of adherence with oral cancer therapy that the authors could find on PubMed or in the reference sections of these PubMed-located articles were included. Adherence and persistence rates ranged from 16{\%} to 100{\%} with different therapies and different methods of measurement. Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described.",
author = "Ruddy, {Kathryn J} and Erica Mayer and Ann Partridge",
year = "2009",
month = "1",
doi = "10.3322/caac.20004",
language = "English (US)",
volume = "59",
pages = "56--66",
journal = "CA Cancer Journal for Clinicians",
issn = "0007-9235",
publisher = "Wiley-Blackwell",
number = "1",

}

TY - JOUR

T1 - Patient adherence and persistence with oral anticancer treatment

AU - Ruddy, Kathryn J

AU - Mayer, Erica

AU - Partridge, Ann

PY - 2009/1

Y1 - 2009/1

N2 - Given the recent significant increase in the use of oral therapies in cancer management, an understanding of patients' adherence to and persistence with oral therapy is crucial. Nonadherence and early cessation may be substantial barriers to the delivery of valuable therapies, and may impair health. Potential obstacles to adherence and persistence include personal characteristics, treatment features, and system factors. Techniques for measuring adherence and persistence include self-report, pill counts, microelectronic monitoring systems (MEMS), prescription database analysis, and the assessment of serum or urine drug levels. This review article describes available data regarding adherence and persistence among patients with cancer, as well as studies of interventions to improve adherence. All reports of studies of adherence with oral cancer therapy that the authors could find on PubMed or in the reference sections of these PubMed-located articles were included. Adherence and persistence rates ranged from 16% to 100% with different therapies and different methods of measurement. Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described.

AB - Given the recent significant increase in the use of oral therapies in cancer management, an understanding of patients' adherence to and persistence with oral therapy is crucial. Nonadherence and early cessation may be substantial barriers to the delivery of valuable therapies, and may impair health. Potential obstacles to adherence and persistence include personal characteristics, treatment features, and system factors. Techniques for measuring adherence and persistence include self-report, pill counts, microelectronic monitoring systems (MEMS), prescription database analysis, and the assessment of serum or urine drug levels. This review article describes available data regarding adherence and persistence among patients with cancer, as well as studies of interventions to improve adherence. All reports of studies of adherence with oral cancer therapy that the authors could find on PubMed or in the reference sections of these PubMed-located articles were included. Adherence and persistence rates ranged from 16% to 100% with different therapies and different methods of measurement. Studies that included educational, behavioral, and multidimensional interventions to improve adherence were also described.

UR - http://www.scopus.com/inward/record.url?scp=58849114208&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=58849114208&partnerID=8YFLogxK

U2 - 10.3322/caac.20004

DO - 10.3322/caac.20004

M3 - Article

VL - 59

SP - 56

EP - 66

JO - CA Cancer Journal for Clinicians

JF - CA Cancer Journal for Clinicians

SN - 0007-9235

IS - 1

ER -